Maurice Borges Vincent

Maurice Borges Vincent

Auto-generated profile, based on publicly available information

Maurice Borges Vincent

Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2014 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
MPMaud Parise
Maud Parise
TKTadeu Takao Almodovar Kubo
Tadeu Takao Almodovar Kubo
TDThomas Martin Doring
Thomas Martin Doring
GTGustavo Tukamoto
Gustavo Tukamoto
MVMaurice Vincent
Maurice Vincent
EGEmerson Leandro Gasparetto
Emerson Leandro Gasparetto
Chronic pain disorders are presumed to induce changes in brain grey and white matters. Few studies have focused CNS alterations in trigeminal neuralgia (TN).

1 June 2007 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
PDF file
MVMaurice Vincent
Maurice Vincent
NHNouchine Hadjikhani
Nouchine Hadjikhani

3 November 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
MVMaurice Vincent
Maurice Vincent
LVLars Viktrup
Lars Viktrup
RNRobert A. Nicholson
Robert A. Nicholson
MOMichael H. Ossipov
Michael H. Ossipov
BVBert B. Vargas
Bert B. Vargas
Migraine is a highly prevalent neurological disease of varying attack frequency. Headache attacks that are accompanied by a combination of impact on daily activities, photophobia and/or nausea are most commonly migraine. The headache phase of a migraine attack has attracted more research, assessment tools and treatment goals than any other feature, characteristic, or phase of migraine. However, the migraine attack may encompass up to 4 phases: the prodrome, aura, headache phase and postdrome. There is growing recognition that the burden of migraine, including symptoms associated with the headache phase of the attack, may persist between migraine attacks, sometimes referred to as the “interictal phase.” These include allodynia, hypersensitivity, photophobia, phonophobia, osmophobia, visual/vestibular disturbances and motion sickness. Subtle interictal clinical manifestations and a patient's trepidation to make plans or commitments due to the unpredictability of migraine attacks may contribute to poorer quality of life. However, there are only a few tools available to assess the interictal burden. Herein, we examine the recent advances in the recognition, description, and assessment of the interictal burden of migraine. We also highlight the value in patients feeling comfortable discussing the symptoms and overall burden of migraine when discussing migraine treatment needs with their provider.

1 November 2003 in Cephalalgia
Verified
Journal Article
Closed access
MVM Vincent
M Vincent
EPE Pedra
E Pedra
JMJ Mourão-Miranda
J Mourão-Miranda
IBIe Bramati
Ie Bramati
AHAr Henrique
Ar Henrique
JMJ Moll
J Moll

1 March 1999 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
PDF file
OSO. Sjaastad
O. Sjaastad
ASA. Stolt‐Nielsen
A. Stolt‐Nielsen
JPJ.A. Pareja
J.A. Pareja
TFT.A. Fredriksen
T.A. Fredriksen
MVM. Vincent
M. Vincent

1 January 2012 in Molecular Pain
Verified
Journal Article
Open access
MDMarcos Fabio DosSantos
Marcos Fabio DosSantos
IMIlkka Kristian Martikainen
Ilkka Kristian Martikainen
TNThiago Dias Nascimento
Thiago Dias Nascimento
TLTiffany M Love
Tiffany M Love
MDMisty Dawn Deboer
Misty Dawn Deboer
ADAlexandre F DaSilva
Alexandre F DaSilva
Background: Although neuroimaging techniques have provided insights into the function of brain regions involved in Trigeminal Neuropathic Pain (TNP) in humans, there is little understanding of the molecular mechanisms affected during the course of this disorder. Understanding these processes is crucial to determine the systems involved in the development and persistence of TNP. Findings: In this study, we examined the regional μ-opioid receptor (μOR) availability in vivo (non-displaceable binding potential BPND) of TNP patients with positron emission tomography (PET) using the μOR selective radioligand [11C]carfentanil. Four TNP patients and eight gender and age-matched healthy controls were examined with PET. Patients with TNP showed reduced μOR BPND in the left nucleus accumbens (NAc), an area known to be involved in pain modulation and reward/aversive behaviors. In addition, the μOR BPND in the NAc was negatively correlated with the McGill sensory and total pain ratings in the TNP patients. Conclusions: Our findings give preliminary evidence that the clinical pain in TNP patients can be related to alterations in the endogenous μ-opioid system, rather than only to the peripheral pathology. The decreased availability of μORs found in TNP patients, and its inverse relationship to clinical pain levels, provide insights into the central mechanisms related to this condition. The results also expand our understanding about the impact of chronic pain on the limbic system.